Cardiogenic shock (CS) is a heterogeneous syndrome reflecting a broad spectrum of shock
severity, diverse etiologies, variable cardiac function, different hemodynamic trajectories …

Background Risk-stratifying patients with cardiogenic shock (CS) is a major unmet need.
The recently proposed Society for Cardiovascular Angiography and Interventions (SCAI) …

Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates
of 30% to 50% despite recent scientific advances. Age is a nonmodifiable risk factor for …

Abstract The Society for Cardiovascular Angiography and Interventions (SCAI) Shock
Classification was developed to create standardized language describing the severity of …

Abstract Background The Cardiogenic Shock Working Group–modified Society for
Cardiovascular Angiography and Interventions (CSWG-SCAI) staging was developed to risk …

In recent years, there have been significant advancements in the understanding, risk-
stratification, and treatment of cardiogenic shock (CS). Despite improved pharmacologic and …

Background Whether age impacts the recently demonstrated survival benefit of microaxial
flow pump (mAFP) treatment in patients with ST-segment elevation myocardial infarction …

Aim Cardiogenic shock (CS) is a hemodynamically complex multisystem syndrome
associated with persistently high morbidity and mortality. As CS is characterized by …

Background: The management of cardiogenic shock (CS) after ACS has evolved over time,
and the development of a multidisciplinary team-based approach has been shown to …

This single-center, observational study assessed the impact of age, gender, and body mass
index (BMI) in patients with cardiogenic shock (CS) on temporary mechanical circulatory …